All lobbying filings

Venn Strategies

Venn Strategies filed a Q3 termination report for Tris Pharma, Inc. on October 20, 2025, reporting $70,000 in lobbying income.

Lobbying for Tris Pharma, Inc. · Biopharmaceutical company

As filed: VENN STRATEGIES for TRIS PHARMA, INC.

All filings by Venn Strategies · Everything Tris Pharma, Inc. has reported

Filing · LD-2 quarterly report Q3 termination

Reporting period

3rd Quarter 2025

July 1 - Sep 30 · Posted Oct 20, 2025

Income

$70,000

What the client paid this registrant for the period.

Client based in

New Jersey

Representation ended

Aug 15, 2025

The registrant reported terminating its work for this client.

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

Policy activities related to treatment of ADHD.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.